A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2019.00910
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2019
Authors
Publisher
Frontiers Media SA